198 related articles for article (PubMed ID: 36944188)
1. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract][Full Text] [Related]
2. Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma.
Schlaepfer Sales CB; Guimarães VSN; Valverde LF; Dias RB; Freitas RD; Siquara da Rocha LO; Coelho de Miranda M; Vilas Bôas DS; Gonçalves Agra IM; Dos Santos JN; Gurgel Rocha CA
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):345-351. PubMed ID: 33512817
[TBL] [Abstract][Full Text] [Related]
3. GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma.
Liu Y; Ren H; Yang MQ; Li JY
Comput Math Methods Med; 2022; 2022():8209700. PubMed ID: 36158119
[TBL] [Abstract][Full Text] [Related]
4. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
[TBL] [Abstract][Full Text] [Related]
5. Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.
Matsuzaki S; Serada S; Hiramatsu K; Nojima S; Matsuzaki S; Ueda Y; Ohkawara T; Mabuchi S; Fujimoto M; Morii E; Yoshino K; Kimura T; Naka T
Int J Cancer; 2018 Mar; 142(5):1056-1066. PubMed ID: 29055044
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma.
Li X; Nie S; Lv Z; Ma L; Song Y; Hu Z; Hu X; Liu Z; Zhou G; Dai Z; Song T; Liu J; Wang S
Cell Death Dis; 2021 Mar; 12(3):261. PubMed ID: 33712571
[TBL] [Abstract][Full Text] [Related]
7. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
Munekage E; Serada S; Tsujii S; Yokota K; Kiuchi K; Tominaga K; Fujimoto M; Kanda M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
Neoplasia; 2021 Sep; 23(9):939-950. PubMed ID: 34332450
[TBL] [Abstract][Full Text] [Related]
8. Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes.
Qiao D; Meyer K; Friedl A
Mol Cell Biol; 2013 Nov; 33(22):4408-21. PubMed ID: 24019070
[TBL] [Abstract][Full Text] [Related]
9. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma.
Harada E; Serada S; Fujimoto M; Takahashi Y; Takahashi T; Hara H; Nakatsuka R; Sugase T; Nishigaki T; Saito Y; Hiramatsu K; Nojima S; Mitsuo R; Ohkawara T; Morii E; Mori M; Doki Y; Kaneda Y; Naka T
Oncotarget; 2017 Apr; 8(15):24741-24752. PubMed ID: 28445969
[TBL] [Abstract][Full Text] [Related]
10. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
[TBL] [Abstract][Full Text] [Related]
11. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
Ling ZN; Hong LL; Wu J; Ling ZQ
Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
[TBL] [Abstract][Full Text] [Related]
12. Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.
Sun CK; Chua MS; He J; So SK
Neoplasia; 2011 Aug; 13(8):735-47. PubMed ID: 21847365
[TBL] [Abstract][Full Text] [Related]
13. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
[TBL] [Abstract][Full Text] [Related]
14. GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-β1/SMAD2 signaling pathway.
Lu F; Chen S; Shi W; Su X; Wu H; Liu M
PLoS One; 2022; 17(6):e0269094. PubMed ID: 35671267
[TBL] [Abstract][Full Text] [Related]
15. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
16. The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation.
de Moraes GFA; Listik E; Justo GZ; Vicente CM; Toma L
BMC Mol Cell Biol; 2021 May; 22(1):26. PubMed ID: 33947326
[TBL] [Abstract][Full Text] [Related]
17. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract][Full Text] [Related]
18. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
19. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with
Watabe T; Kabayama K; Naka S; Yamamoto R; Kaneda K; Serada S; Ooe K; Toyoshima A; Wang Y; Haba H; Kurimoto K; Kobayashi T; Shimosegawa E; Tomiyama N; Fukase K; Naka T
J Nucl Med; 2023 Dec; 64(12):1949-1955. PubMed ID: 37827841
[TBL] [Abstract][Full Text] [Related]
20. The BRCAness Landscape of Cancer.
Guo M; Wang SM
Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
